https://artisanbio.com/artisan-bio-post-template/2026-04-06T17:43:28+00:00https://artisanbio.com/making-better-drugs/2026-04-06T19:55:12+00:00https://artisanbio.com/5-decades-curing-childhood-cancer/2026-05-26T11:56:25+00:00https://artisanbio.com/redefining-a-pediatric-cancer-drug-development/2026-04-21T18:43:07+00:00https://artisanbio.com/redefining-a-pediatric-cancer-drug-development-2/2026-04-23T16:37:50+00:00https://artisanbio.com/across-the-pond-the-sarcoma-uk-5-year-vision/2026-04-30T08:44:16+00:00https://artisanbio.com/2026-0504-daems-paper/2026-06-04T15:31:30+00:00https://artisanbio.com/quality-control-and-childhood-cancer-medicines/2026-05-26T11:52:29+00:00https://artisanbio.com/pediatric-brain-tumors-at-a-glance/2026-05-26T12:01:17+00:00https://artisanbio.com/do-fda-approved-cancer-drugs-really-take-6-years-to-reach-children/2026-06-10T14:29:43+00:00https://artisanbio.com/due-diligence-overdue/2026-06-16T14:45:15+00:00https://artisanbio.com/aacr-from-sidney-farbers-leukemia-pioneership-to-2026/2026-06-19T08:32:23+00:00https://artisanbio.com/the-academic-proposal-for-drug-development-and-clinical-trial-integration/2026-06-23T17:43:49+00:00https://artisanbio.com/global-perspective-of-the-impact-of-cancer-on-children/2026-07-23T13:44:32+00:00https://artisanbio.com/pediatric-early-drug-development/2026-08-14T18:46:58+00:00